AstraZeneca to further develop Targacept's ADHD drug Reuters L) agreed to pay $10 million in milestone payment to further develop Targacept's experimental treatment for attention deficit/hyperactivity disorder (ADHD). ... Targacept's ADHD drug to move forward in studiesForbes Astra paying $10M milestone for ADHD drugPhiladelphia Inquirer AstraZeneca, Targacept shift drug to ADHD trialsThe News Journal Wall Street Journal -Hays Pharma -Local Tech Wire all 43 news articles » |
Santarus, Inc., a specialty biopharmaceutical company, today announced that it has received the $20 million milestone payment previously announced on December 1, 2009 relating to the approval of ZEGERID OTC™ (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules) under its over-the-counter (OTC) licensing agreement with Schering-Plough HealthCare Products, Inc., the consumer healthcare division ...